compared to leukocytes. Based on our own experience, approximately 100 ng of purified total RNA can be isolated from 10 9 platelets. A similar amount can be obtained from as little as 10 4 leukocytes. Despite controversial findings concerning the biological activity of gene transcripts in terms of de novo protein synthesis [3] [4] [5] [6] , it is obvious that transcripts found in platelets are derived from genes that are active in late megakaryopoiesis. The transcriptome represents a useful source of information about the expression state of genes including those that have not yet been considered for platelets. With the introduction of microarray techniques, the complex characterization of cellular transcriptomes evolved to an important approach to investigate physiological and pathophysiological processes. Recently, microarray techniques were applied for mRNA profiling in human platelets of healthy individuals [reviewed in 7] . The importance of the transcriptomic approach in learning about pathomechanisms of platelet disorders was proven by a study of Gnatenko et al. [8] which investigated patients with essential thrombocytemia. It was demonstrated that distinct subtypes of 17β-hydroxysteroid deoxygenases are active in platelets and that the expression pattern of these enzymes is significantly associated with the platelet disorder. The understanding of the important role that platelets play not only in hemostasis and atherothrombosis but also in inflammatory and immunological processes is growing continuously. Most features of the specific platelet function in these physiological and pathophysiological phenomena are determined by the complex molecular structure of the cell surface. The outer platelet surface is characterized by a broad spectrum of different receptors and membrane proteins which determine the reactivity of platelets with various agonists and the adhesion to soluble and cell-bound proteins [9] . The different receptors include platelet-specific glycoprotein (GP) complexes which predominantly mediate binding to matrix proteins, such as thrombin, fibrinogen and collagen. Many of the GPs carry human platelet alloantigens (HPA) relevant in clinical platelet immunology [reviewed in 10]. Other receptors are involved in platelet adhesion to other cells (e.g. P-selectin and PECAM-1) or specifically bind agonists of platelet activation (e.g. PAR1 for thrombin and P2Y1 for ADP). Interestingly, specific receptors and selective transporters of various neurotransmitters, such as serotonin and dopamine, can be found on platelets. Therefore, platelets are used as tools in psychiatric research and as a peripheral model for central serotonergic neurons [11, 12] . The detailed molecular characterization of the platelet surface including receptors, transporters, channels and other membrane-associated proteins will have a great impact on the understanding of cellular functions that have not yet been described in platelets. Scientists have started to apply the new technologies of transcriptomics and proteomics also to platelet research. A detailed description of proteome techniques including their limitations is given in another article published in this issue [44] . This review integrates published as well as some unpublished RNA and protein data to address the question of whether RNA data reflect the actual protein expression in platelets. Whole-genome transcriptomic analyses are much easier to perform than complex proteomic approaches, but we should learn more about the significance of RNA data. With a focus on membrane proteins, we examine how transcriptomic and proteomic studies led to the identification of novel platelet proteins, including proteins previously known in other cells but not in platelets as well as socalled hypothetical proteins of unknown function.
Concordance of Platelet Transcriptome and Proteome Data
Over the past few years, a number of studies have been performed to characterize the platelet transcriptome and proteome [13] [14] [15] [16] [17] [18] [19] [20] . All transcriptome studies identified known platelet gene transcripts as well as transcripts not previously described for platelets [13] [14] [15] . Leukocyte contamination was minimized either by differential centrifugation and magnetic bead separation [13] or by filtration using leukocyte adhesion filters [14] . The efficacy of leukocyte depletion was demonstrated by flow cytometry [13] or by the absence of PCR signals for genomic DNA or leukocyte-specific gene transcripts (e.g. CD15 or CD45) [14] . Gnatenko et al. [13] and McRedmond et al. [15] used the same microarray platform and published the 50 most abundant genes. The majority of transcripts were shared between the two studies. We used a different microarray platform based on 50mer oligonucleotide probes spotted onto glass slides (30K human array; MWG-Biotech, Ebersberg, Germany) and were able to analyze 28,683 individual human genes [2, unpublished data] . This platelet RNA profiling revealed 5,310 (18.5%) positive signals. All of the published top 50 platelet transcripts were also positive in our platelet RNA profile (table 1), except for the gene encoding progesterone receptor membrane component 1 (PGRMC1). The corresponding protein was identified in two proteome studies [17, 20] . McRedmond et al. [15] obtained platelet transcriptome and proteome data with a focus on secreted proteins and compared both molecular profiles. The so-called secretome was obtained from the supernatant of platelets after thrombin stimulation and included 82 distinct proteins. For 70 of these proteins, corresponding RNA data was obtained by microarray analysis. The transcriptome data matched 48 proteins (69%), whereas for the remaining 22 proteins (31%) no gene transcript could be detected. Similar results were found when published proteome data were compared to the transcriptome data: 82 (68%) of 120 platelet proteins identified by O'Neill et al. [17] matched with RNA profiling, and the remaining 38 (32%) were absent in the platelet transcriptome. Only 64 of the 122 platelet proteins identified by Marcus et al. [16] Towards the Identification of Novel Platelet Receptors: Comparing RNA and Proteome Approaches al. [15] Among these, protein and RNA expression matched in 44 cases (69%). We compared our transcriptome data with the to date largest platelet proteomic study [19] which comprised 641 distinct proteins. As an example, among the 69 identified transmembrane proteins, 60 corresponding genes were represented on our microarrays. In 40 cases (67%) the RNA signal was positive and confirmed the proteome findings. Generally, two thirds of platelet proteins identified by complex proteomics can also be detected as corresponding gene transcript by RNA microarray analysis. Thus, when screening for protein expression via a transcriptomic approach, one can expect false-negative results for about one third of the genes. This may be due to i) the limited mRNA stability of these genes, ii) the fact that the level of RNA expression does not correlate with the level of protein expression and the possibility that very low levels of RNA are not detected by microarray analysis, iii) the fact that some proteins may be preformed in megakaryocytes and stored at an earlier stage resulting in mRNA degradation, iv) the fact that proteins are not synthesized by megakaryocytes or platelets but are taken up from plasma or other cells. Especially in platelets where due to the lack of nuclear gene transcription the transcriptome is not dynamic, the stability of mRNA species has a significant impact. It may be concluded that the platelet transcriptome represents the most stable transcripts of genes active during late megakaryopoiesis. A considerable number of mRNA species have not yet been detected by proteomics. For 22 of the 50 most abundant platelet transcripts [13, 15] no corresponding protein has been described by proteomics or classical approaches of protein identification. Interestingly, 7 gene transcripts were identified encoding distinct histones (e.g. H2A histone family members A, L, O and Q). Histones are usually located in the cell nucleus in association with DNA, and therefore it seems unlikely that these proteins can be found in platelets. Another example is ferritin for which mRNA encoding the heavy chain and the light chain has been identified at high levels in all transcriptome studies [13] [14] [15] . None of the proteome studies could confirm the abundance of ferritin. Only one report about the detection of low ferritin levels in platelets (measured by ra- dioimmunoassay) exists in the literature [21] . Further genes identified by transcriptomics but not by proteomics are given in table 1. These findings are probably due to the lack of translation of these transcripts, but may also result from special structural or biochemical characteristics that make these proteins difficult to identify by complex proteomic approaches. For example, mRNA encoding dynein is unambiguously present in platelets [13] [14] [15] , and the functional protein was identified [22] . 
RNA and Protein Data of Known and Novel Platelet Receptors
As mentioned above, the characterization of membrane proteins at the platelet surface is of special interest for a number of reasons: i) identification of novel platelet alloantigens (impact on platelet immunology), ii) identification of adhesion molecules (impact on hemostasis and inflammation) and iii) identification of signaling receptors (impact on platelet agonism). Whole-genome screening for novel platelet membrane proteins by transcriptomics requires less time and effort compared to proteomics but entails limitations concerning significance of data. The platelet transcriptome revealed a significantly higher number of positive receptor and other membrane proteins compared to other functional gene categories [14] . The most abundant transcripts from different functional categories of membrane proteins revealed several interesting findings (table 2) . Among the 10 most abundant cytokine receptor-specific RNAs, 4 encode interleukin receptors: IL-6R, IL-10R, IL-11R and IL-12R. These receptors have not yet been described for platelets. By performing Western blot analysis and flow cytometry with specific monoclonal antibodies, we investigated 3 of these receptors and could demonstrate IL-10R and IL-12R expression on platelets (IL-6R was not detected) (unpublished data). The chemokine receptor 5 (CCR5) gene transcript is highly abundant in platelets, but according to published data, the protein is absent in platelets [23] . We used 2 different monoclonal antibodies and were able to detect the protein with one of them [24] . Furthermore, the platelet transcriptome revealed a number of highly abundant mRNAs encoding neuronal receptors and transporters (e.g. for GABA, serotonin or neurotensin). Further investigations will be undertaken to demonstrate the expression of certain neuronal receptors on platelets. Nicotinic acetylcholine receptors have been identified on endothelial cells [25] . In platelets, one of the most abundant gene transcripts encodes the nicotinic acetylcholine receptor α polypeptide 10 (CHRNA10). If the receptor protein is expressed on platelets, this would represent a further example of similar receptor expression of endothelial cells and platelets already known for P-selectin, PECAM-1, PAR-1 and others. In a recent study, Moebius et al. [20] investigated the platelet proteome using a gel-based approach optimized for membrane proteins. Among the 297 identified distinct proteins, 84 (28.3%) are known to be located in or closely associated with the plasma membrane. Many of them represented known platelet receptors, such as GPs, integrins, P-selectin and PECAM-1. The membrane proteome included several interesting new findings. For example, in addition to the syntaxins 4 and 7 known to be involved in vesicle trafficking in platelets [26, 27] , the syntaxins 6 and 11 were identified. SEC22B and VAMP-A represent further vesicle-associated proteins demonstrated in platelets for the first time. These new proteins could also be detected in the platelet transcriptome [14] . Intercellular junctional proteins, such as JAM, are known to be expressed on platelets [reviewed in 28] . Proteome studies confirmed the expression of JAM-A and JAM-C and added information about further structural components of junctions, such as pannexin 1 and the PDZ/LIM domain protein 1 [19, 20] . RGS10, RGS19, RGS20 and STIM1 are signaling receptors described in the platelet proteome and presumed to be located in the plasma membrane. Two signaling molecules, RGS10 and RGS18, were identified in a differential proteome analysis [29] . Both, the transcriptomic and the proteomic approach yielded proteins presumably located in the plasma membrane and not described in platelets before.
Hypothetical Proteins with Transmembrane Features
The proteome study of platelet membranes [20] revealed novel potential receptors, such as the hypothetical proteins MGC5508, KIAA0747 and FLJ11036 (table 3) . Computer analysis of the protein sequence revealed characteristic transmembrane domains (TMDs) for these proteins. The hypothetical proteins identified by Martens et al. [19] included 4 proteins with at least one TMD: KIAA0152, similar to RIKEN cDNA F30003B03 and 9430029K10, and a protein similar to integrin β1 according to BLAST search ( Major parts of both proteins were predicted to be located outside of the cell. Generally, the data concerning hypothetical proteins is very similar to that of other gene categories, i.e. proteins can be found in both the platelet transcriptome and proteome or only in one of the two molecular profiles. The putative membrane proteins identified exclusively in the transcriptome represent encouraging candidates for further experimental investigation. [14] and/or proteome [19, 20] These proteins may be identified by using specific immunological approaches instead of proteomic screening due to the limitations of these methods concerning membrane-anchored proteins.
Conclusion
Integration of platelet transcriptomes and proteomes demonstrated that some limitations exist regarding the significance of RNA data. On the other hand, transcriptome analysis via microarray hybridization is easier to perform compared to the complex proteome techniques. The significant limitations of the various proteomic methods, especially concerning hydrophobic proteins, protein glycosylation or proteins with tight folding, have been recognized and were discussed in a recent report of the ISTH Platelet Physiology Subcommittee [33, 34] . Protein glycosylation and the identification of glycoprotein isoforms was achieved in a proteomic approach in which lectin affinity chromatography as well as chemical trapping of protein-bound oligosaccharides was applied [35] . Thus, the limitations of current proteomic methods might be solved in future. In conclusion, RNA profiling represents a suitable approach for identification of novel gene functions in platelets. Comparative profiling (e.g. patients vs. healthy individuals) is definitely appropriate for the identification of genes associated with platelet disorders. This has already been proven [8, 36] and was discussed in a recent review [37] . Views still differ regarding the biological role of gene transcripts in terms of de novo protein biosynthesis in platelets. A number of studies showed newly synthesized proteins after platelet stimulation [38] [39] [40] , but it was also shown that de novo synthesis of cytokines in platelet preparations is strongly correlated with the amount of leukocyte contamination [41, 42] . Recently, active spliceosomes were identified in the cytoplasm of megakarycytes and platelets [43] . The signal-dependent splicing of pre-mRNA indicated regulation of protein biosynthesis in platelets. In our opinion, the impact of active spliceosomes on the function of circulating platelets is still uncertain.
